Skip to content

Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass

CSP #517 - Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00032630
Acronym
ROOBY
Enrollment
2203
Registered
2002-03-28
Start date
2002-04-30
Completion date
2008-04-30
Last updated
2014-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease

Brief summary

Ischemic heart disease is one of the most frequent diagnoses in the VA system. Moreover, 5,819 coronary artery bypass graft (CABG-only) procedures were performed in the VA in Fiscal Year (FY) 1999. Throughout VA and non-VA cardiac surgery programs nationwide, myocardial revascularization is now being performed using two surgical techniques. One technique is performed with cardiopulmonary bypass (CPB) usually with cardioplegic arrest (on-pump) and the other without CPB on a beating heart (off-pump). The overall purpose of this proposed randomized, controlled, clinical trial is to rigorously evaluate the impact of using an on-pump versus off-pump surgical technique for coronary artery bypass graft (CABG-only) procedures (performed with a traditional median sternotomy incision) upon patient clinical outcomes and resource utilization.

Detailed description

Primary Hypotheses: The study has two primary hypotheses to evaluate the impact of using an off-pump versus an on-pump surgical technique for CABG procedures. One is a short term objective to assess the immediate impact of the two surgical techniques while the second assesses the long-term impact of the two techniques: 1) Short-Term Null Hypothesis: For patients having CABG-only procedures performed, there will be no difference in the short-term composite clinical outcome (30 day death or major morbidity) between patients randomized to the on-pump and off-pump procedures, 2) Long-Term Null Hypothesis: For patients undergoing CABG-only procedures, there will be no difference in long-term clinical outcome as measured by one year mortality and/or acute myocardial infarction prior to one year and/or a subsequent revascularization procedure within one year between patients randomized to the on-pump and off-pump procedures. Secondary Hypotheses: Major secondary objectives are to determine if there are differences in patients undergoing CABG-only procedures using the on-pump and off-pump techniques for 1) long-term completeness of revascularization, 2) one year graft patency and stenosis rates as determined by angiography at one year, and 3) short-term completeness of revascularization. Other secondary objectives are to evaluate the two surgical techniques on 1) changes in neuropsychological function, 2) traditional clinical outcomes, 3) general and disease specific quality of life, and 4) use of system resources. Intervention: Patients requiring an elective or urgent CABG-only (no other procedures to be done) surgical procedure will be randomized to either the off-pump procedure or to the on-pump procedure. Primary Outcomes: The short-term primary outcome measure is a composite measure of death, repeat cardiac surgery, new technical support, cardiac arrest, coma, prolonged stroke and/or renal failure requiring dialyses occurring within 30 days of surgery or prior to discharge, whichever is latest. The long-term primary outcome measure is a composite of death, acute myocardial infarction, and/or subsequent revascularization procedure prior to one year post-surgery. Study Abstract: Ischemic heart disease is one of the most frequent diagnoses in the VA system. Moreover, 5,819 coronary artery bypass graft (CABG-only) procedures were performed in the VA in FY 1999. Throughout VA and non-VA cardiac surgery programs nationwide, myocardial revascularization is now being performed using two surgical techniques. One technique is performed with cardiopulmonary bypass (CPB) usually with cardioplegic arrest (on-pump) and the other without CPB on a beating heart (off-pump). The overall purpose of this proposed randomized, controlled, clinical trial is to rigorously evaluate the impact of using an on-pump versus off-pump surgical technique for coronary artery bypass graft (CABG-only) procedures (performed with a traditional median sternotomy incision) upon patient clinical outcomes and resource utilization.

Interventions

PROCEDURECoronary artery bypass - on-pump

CABG procedure performed on heart lung machine

PROCEDURECoronary artery bypass - off-pump

CABG procedure performed without the use of the heart lung machine

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Elective or Urgent CABG * CABG only procedure to be performed

Exclusion criteria

* Patient's surgeon is not a participant that meets study off-pup criteria * Valve or Valve/CABG procedure * Emergent, hemodynamically unstable, or in cardiogenic shock preoperatively * Moderate, moderate, to severe, or severe valvular disease * Enrolled in another therapeutic or interventional study * Majority of diffusely diseased distal vessels * Clinical Care Team has reservations * History of on-compliance * Patient preference for treatment arm * Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Short-term End Point30 dayShort-term end point was a composite of death or major complications (reoperation, new mechanical support, cardiac arrest, coma, stroke, or renal failure requiring dialysis) occuring within 30 days after surgery or before discharge, whichever was later.
Long-term Compositeone-yearLong-term composite endpoint was death from any cause within 1 year, nonfatal myocardial infarction between 30 days and 1 year, or repeat revascularization between 30 days and 1 year.

Countries

United States

Participant flow

Recruitment details

From February 2002 to May 2007, a total of 9663 patients who were scheduled for urgent or elective Coronary Artery Bypass Graft (CABG) were screened for enrollment. Of these, 7460 patients were excluded, mostly because of diffusely diseased or small coronary arteries. Overall,1099 patients were randomized to on-pump and 1104 randomized to off-pump

Participants by arm

ArmCount
On Pump
Coronary artery bypass performed on a non beating heart using a heart-lung machine
1,099
Off Pump
Coronary artery bypass performed on a beating heart with no heart-lung machine
1,104
Total2,203

Baseline characteristics

CharacteristicOff PumpOn PumpTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
433 Participants400 Participants833 Participants
Age, Categorical
Between 18 and 65 years
671 Participants699 Participants1370 Participants
Age, Continuous63.0 years
STANDARD_DEVIATION 8.5
62.5 years
STANDARD_DEVIATION 8.5
62.74 years
STANDARD_DEVIATION 8.49
Region of Enrollment
United States
1104 participants1099 participants2203 participants
Sex: Female, Male
Female
7 Participants6 Participants13 Participants
Sex: Female, Male
Male
1097 Participants1093 Participants2190 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1,0990 / 1,104
serious
Total, serious adverse events
201 / 1,099220 / 1,104

Outcome results

Primary

Long-term Composite

Long-term composite endpoint was death from any cause within 1 year, nonfatal myocardial infarction between 30 days and 1 year, or repeat revascularization between 30 days and 1 year.

Time frame: one-year

ArmMeasureValue (NUMBER)
On PumpLong-term Composite78 Participants
Off PumpLong-term Composite105 Participants
Primary

Short-term End Point

Short-term end point was a composite of death or major complications (reoperation, new mechanical support, cardiac arrest, coma, stroke, or renal failure requiring dialysis) occuring within 30 days after surgery or before discharge, whichever was later.

Time frame: 30 day

ArmMeasureValue (NUMBER)
On PumpShort-term End Point61 participants
Off PumpShort-term End Point77 participants

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026